SE9803482D0 - Ion exchange tumor targeting (IETT) - Google Patents

Ion exchange tumor targeting (IETT)

Info

Publication number
SE9803482D0
SE9803482D0 SE9803482A SE9803482A SE9803482D0 SE 9803482 D0 SE9803482 D0 SE 9803482D0 SE 9803482 A SE9803482 A SE 9803482A SE 9803482 A SE9803482 A SE 9803482A SE 9803482 D0 SE9803482 D0 SE 9803482D0
Authority
SE
Sweden
Prior art keywords
iett
ion exchange
tumor targeting
tumor
compound
Prior art date
Application number
SE9803482A
Other languages
English (en)
Inventor
Anders Holmberg
Original Assignee
Anders Holmberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anders Holmberg filed Critical Anders Holmberg
Priority to SE9803482A priority Critical patent/SE9803482D0/sv
Publication of SE9803482D0 publication Critical patent/SE9803482D0/sv
Priority to JP2000575543A priority patent/JP2002527407A/ja
Priority to AT99970330T priority patent/ATE489971T1/de
Priority to IL14229299A priority patent/IL142292A0/xx
Priority to AU14247/00A priority patent/AU759251B2/en
Priority to DE69943003T priority patent/DE69943003D1/de
Priority to US09/807,542 priority patent/US6569841B1/en
Priority to EP99970330A priority patent/EP1137441B1/en
Priority to CA002347424A priority patent/CA2347424C/en
Priority to PCT/SE1999/001837 priority patent/WO2000021571A1/en
Priority to NO20011817A priority patent/NO20011817L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/06Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
SE9803482A 1998-10-13 1998-10-13 Ion exchange tumor targeting (IETT) SE9803482D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9803482A SE9803482D0 (sv) 1998-10-13 1998-10-13 Ion exchange tumor targeting (IETT)
PCT/SE1999/001837 WO2000021571A1 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting (iett)
AU14247/00A AU759251B2 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting (IETT)
AT99970330T ATE489971T1 (de) 1998-10-13 1999-10-12 Ionaustausch-tumor zielausrichtung
IL14229299A IL142292A0 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting
JP2000575543A JP2002527407A (ja) 1998-10-13 1999-10-12 イオン交換腫瘍ターゲティング(iett)
DE69943003T DE69943003D1 (de) 1998-10-13 1999-10-12 Ionaustausch-tumor zielausrichtung
US09/807,542 US6569841B1 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting (IETT)
EP99970330A EP1137441B1 (en) 1998-10-13 1999-10-12 Ion exchange tumor targeting (iett)
CA002347424A CA2347424C (en) 1998-10-13 1999-10-12 Use of dextran covalently bound to charged groups for selective targeting of tumor by local, intratumoral or intracavitary administration
NO20011817A NO20011817L (no) 1998-10-13 2001-04-10 Ionebytte-tumormålsöking (IETT)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803482A SE9803482D0 (sv) 1998-10-13 1998-10-13 Ion exchange tumor targeting (IETT)

Publications (1)

Publication Number Publication Date
SE9803482D0 true SE9803482D0 (sv) 1998-10-13

Family

ID=20412924

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803482A SE9803482D0 (sv) 1998-10-13 1998-10-13 Ion exchange tumor targeting (IETT)

Country Status (11)

Country Link
US (1) US6569841B1 (sv)
EP (1) EP1137441B1 (sv)
JP (1) JP2002527407A (sv)
AT (1) ATE489971T1 (sv)
AU (1) AU759251B2 (sv)
CA (1) CA2347424C (sv)
DE (1) DE69943003D1 (sv)
IL (1) IL142292A0 (sv)
NO (1) NO20011817L (sv)
SE (1) SE9803482D0 (sv)
WO (1) WO2000021571A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010764A0 (sv) * 2001-04-11 2001-04-11 Map Medical Technologies Oy Kationiska dextran derivater användbara som njurskyddande ämnen
US8377484B1 (en) 2004-05-06 2013-02-19 Maria V. Tsiper Tumor encapsulation for prevention and treatment of metastatic cancer disease
JP2009532552A (ja) * 2006-04-07 2009-09-10 アドシア 二官能化された多糖類
FI119513B (sv) * 2007-03-07 2008-12-15 Dextech Medical Ab Modifierade hydroxipolymerkonjugater som har letal verkan på tumörceller
FR2919189A1 (fr) * 2007-07-26 2009-01-30 Cyclopharma Sa Lab Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.
US7998368B2 (en) * 2007-11-26 2011-08-16 United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Aqueous solution dispersement of carbon nanotubes
WO2009124580A1 (en) * 2008-04-07 2009-10-15 Dextech Medical Ab Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
KR101450838B1 (ko) 2012-02-08 2014-10-15 가톨릭대학교 산학협력단 표적화 화학요법을 위한 암 인식 지능형 폴리펩티드 및 이의 제조방법
DE102014016901B4 (de) * 2014-09-17 2021-08-12 Friedrich-Schiller-Universität Jena Verfahren zur Herstellung für neue Dextranderivate als Wirkstoffträgersystem und deren Verwendung
FI127538B (sv) 2016-06-22 2018-08-31 Dextech Medical Ab Modifierade dextrankonjugater
PL240772B1 (pl) * 2018-06-11 2022-06-06 Nanothea Spolka Akcyjna Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms

Also Published As

Publication number Publication date
CA2347424A1 (en) 2000-04-20
EP1137441A1 (en) 2001-10-04
DE69943003D1 (de) 2011-01-13
CA2347424C (en) 2009-12-08
ATE489971T1 (de) 2010-12-15
WO2000021571A1 (en) 2000-04-20
NO20011817D0 (no) 2001-04-10
IL142292A0 (en) 2002-03-10
AU759251B2 (en) 2003-04-10
US6569841B1 (en) 2003-05-27
JP2002527407A (ja) 2002-08-27
AU1424700A (en) 2000-05-01
EP1137441B1 (en) 2010-12-01
NO20011817L (no) 2001-04-10

Similar Documents

Publication Publication Date Title
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
CY1109881T1 (el) Νεοαγγειακα-συγκεκριμενα πεπτιδια
ES2141128T3 (es) Combinacion de agentes anti-hormonales y moleculas de fijacion.
NZ500657A (en) Interleukin-3 gene therapy for cancer
NO20011817D0 (no) Ionebytte-tumormålsöking (IETT)
PL335140A1 (en) Therapeutic agent for treating lymphatic system carcinomas
BR0306715A (pt) Métodos para diagnóstico e tratamento de tumores
ATE316134T1 (de) Zusammensetzung mit alpha-glycosylceramid zur stärkung zellulärer immunogenität
BR0208017A (pt) Combinação compreendendo combretastatina e agentes anticâncer
WO2004110255A3 (en) Antineoplastic agents targeted via glut transporters
NZ309171A (en) use of apoptin as an antitumour agent which specifically kills tumour and not normal cells
NZ240926A (en) Radioactively labelled modified oligonucleotide labelled with a therapeutic isotope and compositions thereof
AU3260093A (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
AU5992500A (en) Compound derived from an offset orf of the ice gene
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
DE60235085D1 (de) Herstellungsverfahren von derivate von bisphosphonaten
WO2000078361A3 (en) Methods of imaging and targeting tumor vasculature
MX9700398A (es) Solucion para la modificacion de tumores cancerosos.
CY1108790T1 (el) Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου